Jyong Biotech Ltd. Ordinary Shares

MENS · NASDAQ · Healthcare / Biotechnology

1.76USD+0.08 (+4.76%)

Price History

Full chart

Market Stats

Previous Close1.68

Open1.73

Day Range1.71 – 1.83

52-Week Range1.43 – 63.00

Volume27.03K

Market Cap154.34M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.06

Dividend Yield0.00%

50-Day Avg2.20

200-Day Avg3.11

About

Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMs. Fu-Feng Kuo
Employees27
HeadquartersNo. 95, Xintai 5th Road, New Taipei City, Taiwan, 221, USA
Websitehttps://jyongbio.com

Leadership

Ms. Fu-Feng KuoCEO & Chairwoman of the Board · b. 1958
Ms. Wei ZhangChief Financial Officer · b. 1981
Dr. Fenglin Hsu Ph.D.CTO & Director · b. 1949
Ms. Wanwen SuChief Science Officer · b. 1975

Financials

Income Statement

Currency: USD	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	-	0	0	0	0	0
Cost of Revenue	-	121.00K	122.00K	127.00K	120.00K	100.00K
Gross Profit	-	-121.00K	-122.00K	-127.00K	-120.00K	-100.00K
Operating Expense	-	2.28M	2.71M	2.67M	1.94M	2.51M
Operating Income	-2.45M	-2.40M	-2.83M	-2.80M	-2.06M	-2.61M
EBITDA	-2.34M	-3.24M	-5.74M	-3.52M	-1.86M	-2.51M
Net Income	-1.92M	-4.20M	-6.63M	-4.40M	-3.02M	-4.67M
R&D	1.51M	1.56M	1.29M	1.07M	927.00K	731.00K
Interest Expense	832.00K	835.00K	765.00K	757.00K	1.03M	2.54M

Balance Sheet

Currency: USD	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	12.84M	9.43M	8.74M	8.25M	6.37M	20.78M
Total Liabilities	32.05M	32.76M	38.38M	42.32M	42.88M	45.68M
Total Equity	-19.20M	-23.32M	-29.63M	-34.07M	-36.52M	-24.91M
Cash	3.56M	551.00K	718.00K	177.00K	98.00K	1.18M
Total Debt	13.60M	11.79M	14.25M	16.69M	18.14M	18.55M
Net Debt	10.04M	11.24M	13.53M	16.51M	18.04M	17.37M

Cash Flow

Currency: USD	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-1.09M	-1.98M	-2.97M	-2.60M	-3.62M	-3.04M
Investing Cash Flow	731.00K	-1.31M	1.39M	95.00K	-	-13.51M
Financing Cash Flow	4.91M	-1.38M	3.33M	2.03M	1.99M	17.63M
Capital Expenditure	88.00K	137.00K	246.00K	0	0	0
Free Cash Flow	-1.18M	-2.12M	-3.22M	-2.60M	-3.62M	-3.04M
FCF to OCF	108.10%	106.91%	108.28%	100.00%	100.00%	100.00%

Earnings

Report Date	Apr 23, 2025
EPS Estimate	0.00
EPS Actual	-0.02
Surprise	-
Timing	-

Key Statistics & Ratios

Market Cap154.34M

Enterprise Value176.23M

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.00

Price / Book0.00

EPS-0.06

Book Value-0.336

Revenue (TTM)0

Gross Profit (TTM)0

EBITDA-2.51M

Profit Margin0.00%

Operating Margin0.00%

Return on Equity0.00%

Return on Assets-12.01%

Shares Outstanding74.23M

Shares Float26.94M

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Ownership Breakdown

Institutions: 0.76%
Insiders: 62.20%
Retail / Other: 37.04%

Top Institutional Holders

BlackRock Inc
258.76K0.35%
Geode Capital Management, LLC
64.23K0.09%
UBS Group AG
37.36K0.05%
China Universal Asset Mgmt Co.Ltd
12.10K0.02%
HRT FINANCIAL LLC
11.77K0.02%
Tower Research Capital LLC
11.70K0.02%
State of Wyoming
11.21K0.02%
Morgan Stanley - Brokerage Accounts
6.30K0.01%
JPMorgan Chase & Co
5.68K0.01%
Barclays PLC
5.19K0.01%
Mirae Asset Global Investments (Korea) Co Ltd
3.40K0.00%
Citigroup Inc
2.79K0.00%
BNP Paribas Arbitrage, SA
1.88K0.00%

Top Fund Holders

iShares Biotechnology ETF
216.82K0.29%
iShares Nasdaq US Biotech ETF USD Acc
57.17K0.08%
Fidelity Nasdaq Composite Index
46.71K0.06%
Fidelity Nasdaq Composite ETF
26.71K0.04%
China Universal NASDAQ Bio-Tch ETF(QDII)
12.10K0.02%
Invesco Nasdaq Biotechnology ETF
4.69K0.01%
ProShares Ultra Nasdaq Biotechnology
2.72K0.00%